Skip to content
Screener

Alkermes ALKS Accrued Sales Discounts Allowances And Reserves

Accrued Sales Discounts Allowances And Reserves at other companies

JAK
Jakks PacificJAKK
$26.74M+1.9%
Rocket Companies logo
Rocket CompaniesRKT
$135M
Rocket Companies logo
Rocket CompaniesRKT
$135M
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$130.87M
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$132.1M
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$130.87M

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.32B+89.9%
Enterprise value$9.38B+139%
P/E125.9×+113×
P/S+2.1×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept alks:AccruedSalesDiscountsAllowancesAndReserves.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemJune 30, 2026December 31, 2025
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable and accrued expenses$332,469$289,565
Accrued sales discounts, allowances and reserves295,645247,126
Operating lease liabilities—short-term7,4776,746
Current portion of long-term debt26,500
Total current liabilities662,091543,437
OPERATING LEASE LIABILITIES—LONG-TERM61,97663,253

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's accrued sales discounts allowances and reserves?
Alkermes (ALKS) reported accrued sales discounts allowances and reserves of $295.65M in Q2 2026.
How has Alkermes's accrued sales discounts allowances and reserves changed year-over-year?
Alkermes's accrued sales discounts allowances and reserves increased by 16.8% year-over-year, from $253.17M to $295.65M.
What is the long-term trend for Alkermes's accrued sales discounts allowances and reserves?
Over 4 years (2021 to 2025), Alkermes's accrued sales discounts allowances and reserves has grown at a 1.0% compound annual growth rate (CAGR), from $237.22M to $247.13M.
What does accrued sales discounts allowances and reserves mean?
This represents estimated liabilities for rebates, chargebacks, and discounts owed to customers or distributors based on sales activity. It is critical for pharmaceutical companies to accurately estimate these contra-revenue items to reflect net revenue correctly.

Ask your AI about Alkermes's accrued sales discounts allowances and reserves.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude